Next Article in Journal
Potential of Intestinal Current Measurement for Personalized Treatment of Patients with Cystic Fibrosis
Next Article in Special Issue
A Pharmacogenetic Study of CYP2C19 in Acute Coronary Syndrome Patients of Colombian Origin Reveals New Polymorphisms Potentially Related to Clopidogrel Therapy
Previous Article in Journal
The Equitable Implementation of Cystic Fibrosis Personalized Medicines in Canada
Previous Article in Special Issue
SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability
 
 
Review

Article Versions Notes

J. Pers. Med. 2021, 11(5), 383; https://doi.org/10.3390/jpm11050383
Action Date Notes Link
article pdf uploaded. 7 May 2021 14:25 CEST Version of Record https://www.mdpi.com/2075-4426/11/5/383/pdf-vor
article pdf uploaded. 7 May 2021 14:51 CEST Updated version of record https://www.mdpi.com/2075-4426/11/5/383/pdf-vor
article xml file uploaded 8 May 2021 10:45 CEST Original file -
article xml uploaded. 8 May 2021 10:45 CEST Update -
article pdf uploaded. 8 May 2021 10:45 CEST Updated version of record https://www.mdpi.com/2075-4426/11/5/383/pdf
article html file updated 8 May 2021 10:47 CEST Original file -
article xml file uploaded 23 May 2021 14:24 CEST Update -
article xml uploaded. 23 May 2021 14:24 CEST Update https://www.mdpi.com/2075-4426/11/5/383/xml
article html file updated 23 May 2021 14:25 CEST Update -
article html file updated 26 July 2022 18:27 CEST Update https://www.mdpi.com/2075-4426/11/5/383/html
Back to TopTop